Kimia Biosciences Ltd

Fri 4/09/2026,15:23:0 | BSE : KIMIABL

₹29.270.77 (2.70%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 29.25

Previous Close

₹ 28.50

Volume

2673

Mkt Cap ( ₹ Cr)

₹ 138.48

High

₹ 29.50

Low

₹ 29.00

52 Week High

₹ 43.28

52 Week Low

₹ 23.20

Book Value Per Share

₹ 3.82

Dividend Yield

₹ 0.00

Face Value

₹₹1.00

What's Your Call?

Collective community sentiment on Kimia Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Kimia Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Kimia Biosciences - Reg. 34 (1) Annual Report.

    4 Sep 2026, 10:59PM Thirty Third Annual Report for the Financial Year 2025-2026 of Kimia Biosciences Limited
  • Kimia Biosciences - Intimation Of Cut-Off Date/ Record Date, E-Voting And AGM Date For The 33Rd Annual General Meeting.

    4 Sep 2026, 7:25PM Intimation of Cut off Date/ Record Date, E-Voting and AGM date for the 33rd Annual General Meeting
  • Kimia Biosciences - Intimation Of 33Rd Annual General Meeting Of The Company Proposed To Be Held On September 28, 2026 At 3:0

    4 Sep 2026, 4:26PM Intimation of 33rd Annual General Meeting of the Company proposed to be held on September 28, 2026 at 03:00 P.M. through Video Conferencing/ Other Aud
  • Kimia Biosciences - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On September 03, 2026 Und

    3 Sep 2026, 6:48PM Outcome of the Meeting of the Board of Directors held on September 03, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requir
  • Kimia Biosciences Q1 net profit down 41.67% at Rs 0.35 cr

    25 Aug 2026, 8:30PM The company reported standalone net profit of Rs 0.35 crore for the quarter ended June 30, 2026 as compared to Rs 0.60 crore in the same period last y
  • Kimia Biosciences - Unaudited Financial Results For The First Quarter Ended June 30, 2026

    10 Aug 2026, 5:13PM Approval of unaudited financial result (Standalone) for quarter ended june 30, 2026.
  • Kimia Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Held On August 10, 2026 (Monday)

    10 Aug 2026, 4:53PM Pursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we
  • Kimia Biosciences - Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations, 2015 -Intimation Of Meeting Of Boa

    3 Aug 2026, 3:58PM Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider an
  • Kimia Biosciences - Announcement under Regulation 30 (LODR)-Change in Management

    1 Aug 2026, 11:18PM Change in Management, appointment of Cost Auditor, Internal Auditor, Secretarial Auditor and Discountinuance/ Cessation of Secretarial Auditor
  • Kimia Biosciences - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 1, 2026 Under R

    1 Aug 2026, 11:14PM Outcome of the Meeting of the Board of Directors held on August 1, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requiremen
  • Kimia Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 1:40PM As of June 2026, 74.94% is owned by Indian Promoters and 25.06% by Public. <p align=justify> Top Promoter holding highest number of shares of Kimia Bi

Key fundamentals

Evaluate the intrinsic value of Kimia Biosciences Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 52.3484 48.8621 49.5394 63.7096 55.5039
Liabilities 52.3484 48.8621 49.5394 63.7096 55.5039
Equity 4.7313 4.7313 4.7313 4.7313 4.7313
Gross Profit 14.2673 20.2498 -0.4834 -4.9759 0.6314
Net Profit 7.4337 9.6124 -5.3087 -9.3522 -3.703
Cash From Operating Activities 10.844 21.3144 14.5348 -6.77 0
NPM(%) 6.47 8.08 -5.06 -7.27 -2.96
Revenue 114.8838 118.9208 104.8765 128.516 124.9009
Expenses 100.6165 98.671 105.3599 133.4919 124.2695
ROE(%) 41.12 53.17 -29.36 -51.74 -20.48

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Kimia Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 863.00 -0.52 21.76 16.70 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 109.90 -0.68 1563.29 60.87 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.42 0.72 0.00 126.39 -39.50 0.00
Astec Lifesciences Ltd 552.30 -3.93 0.00 65.22 -363.14 0.00

Company Info

Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-

Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-

Parent Organisation

Kimia Biosciences Ltd.

Founded

27/09/1993

Managing Director

Mr.Sameer Goel

NSE Symbol

FAQ